Company

Alibaba Health Information Technology Limited

阿里健康

Alibaba Health Information Technology Limited is a health technology company that appears in elsewhere's corpus primarily as an investor and as a former employer of key figures in the AI-pharma crossover space. Per a 2023 FreeS Capital funding announcement, it participated in the Pre-A and Pre-A+ rounds of chip-based biotech startup Xinsu Technology alongside Green Power Capital, Fosun Pharma's Fosun Health Capital, and existing investor FreeS Capital . More prominently in recent coverage, it is the former employer of Zhigang Chen, who served as chief architect and head of algorithms and modeling there before founding C12.ai (now HETAN Intelligence), a lab-robotics company that raised 50 million yuan in March 2026 . As 暗涌Waves reported, Chen's trajectory from Alibaba Health to Tencent Medical Big Data Lab to WuXi AppTec's first chief digital officer and then to entrepreneurship illustrates the talent flow from internet health platforms into AI-driven drug discovery . Elsewhere's corpus does not contain a direct profile of Alibaba Health's own business lines or financials.

AI-generated — may contain errors, please verify.

Alibaba Health Information Technology LimitedCompany
阿里健康
渲染中…
Mentioned in 8 articles

Coverage